FIELD: phthisiology. SUBSTANCE: in the first days of antituberculous chemotherapy, patient additionally receives endobronchially surfactant BL or HL in doses 10-25 mg daily or each other day over 3-8-weeks period. Such strategy reduces treatment time, suppress bacterioexcretion in the course of 1 to 4 months, eliminates destructive alterations in 2 to 6 months, and stabilizes tuberculosis process in treatment- unpromising patients. EFFECT: enhanced treatment efficiency. 3 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PULMONARY ORGANS TUBERCULOSIS | 2005 |
|
RU2299068C2 |
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
| METHOD FOR PREDICTION OF RISK OF MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO FLUOROQUINOLONES IN TUBERCULOSIS PATIENTS WITH MULTIPLE RESISTANCE | 2014 |
|
RU2558992C1 |
| METHOD FOR DETERMINING THE DURATION OF AN INTENSIVE PHASE OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN CHILDREN WITHOUT BACTERIAL RELEASE AND WITHOUT A RISK OF MULTIPLE AND BROAD DRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2020 |
|
RU2737337C1 |
| METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2004 |
|
RU2253460C1 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
| METHOD FOR CHOOSING THERAPEUTIC APPROACH FOR PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS | 2015 |
|
RU2602683C1 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS IN THE TREATMENT OF RESPIRATORY TUBERCULOSIS IN CHILDREN FROM FOCI WITH MULTIDRUG RESISTANCE OF THE PATHOGEN | 2022 |
|
RU2784464C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
